Human SARS-CoV-2 challenge uncovers local and systemic response dynamics.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
19 Jun 2024
Historique:
received: 24 02 2023
accepted: 16 05 2024
medline: 20 6 2024
pubmed: 20 6 2024
entrez: 19 6 2024
Statut: aheadofprint

Résumé

The COVID-19 pandemic is an ongoing global health threat, yet our understanding of the dynamics of early cellular responses to this disease remains limited

Identifiants

pubmed: 38898278
doi: 10.1038/s41586-024-07575-x
pii: 10.1038/s41586-024-07575-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s).

Références

Wagstaffe, H. R. et al. Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults. Sci. Immunol. 9, eadj9285 (2024).
doi: 10.1126/sciimmunol.adj9285
Blanco-Melo, D. et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181, 1036–1045.e9 (2020).
doi: 10.1016/j.cell.2020.04.026
Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718–724 (2020).
doi: 10.1126/science.abc6027
Schulte-Schrepping, J. et al. Severe COVID-19 is marked by a dysregulated myeloid cell compartment. Cell 182, 1419–1440.e23 (2020).
doi: 10.1016/j.cell.2020.08.001
Stephenson, E. et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nat. Med. 27, 904–916 (2021).
doi: 10.1038/s41591-021-01329-2
Yoshida, M. et al. Local and systemic responses to SARS-CoV-2 infection in children and adults. Nature 602, 321–327 (2022).
doi: 10.1038/s41586-021-04345-x
Killingley, B. et al. Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults. Nat. Med. 28, 1031–1041 (2022).
doi: 10.1038/s41591-022-01780-9
Fears, A. C. et al. The dynamics of γδ T cell responses in nonhuman primates during SARS-CoV-2 infection. Commun. Biol. 5, 1380 (2022).
doi: 10.1038/s42003-022-04310-y
Frere, J. J. et al. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery. Sci. Transl. Med. 14, eabq3059 (2022).
doi: 10.1126/scitranslmed.abq3059
Loske, J. et al. Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children. Nat. Biotechnol. 40, 319–324 (2022).
doi: 10.1038/s41587-021-01037-9
Singanayagam, A. et al. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Lancet Infect. Dis. 22, 183–195 (2022).
doi: 10.1016/S1473-3099(21)00648-4
Rosenheim, J. et al. SARS-CoV-2 human challenge reveals single-gene blood transcriptional biomarkers that discriminate early and late phases of acute respiratory viral infections. Preprint at medRxiv https://doi.org/10.1101/2023.06.01.23290819 (2023).
Hinks, T. S. C. & Zhang, X.-W. MAIT cell activation and functions. Front. Immunol. https://doi.org/10.3389/fimmu.2020.01014 (2020).
Chandran, A. et al. Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections. Cell Rep. Med. 3, 100557 (2022).
doi: 10.1016/j.xcrm.2022.100557
Wang, K. et al. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct. Target. Ther. 5, 283 (2020).
doi: 10.1038/s41392-020-00426-x
Brunetti, N. S. et al. SARS-CoV-2 uses CD4 to infect T helper lymphocytes. eLife https://doi.org/10.7554/eLife.84790 (2023).
Shen, X.-R. et al. ACE2-independent infection of T lymphocytes by SARS-CoV-2. Signal Transduct. Target. Ther. 7, 83 (2022).
doi: 10.1038/s41392-022-00919-x
Wosen, J. E., Mukhopadhyay, D., Macaubas, C. & Mellins, E. D. Epithelial MHC class II expression and its role in antigen presentation in the gastrointestinal and respiratory tracts. Front. Immunol. 9, 2144 (2018).
doi: 10.3389/fimmu.2018.02144
Madissoon, E. et al. A spatially resolved atlas of the human lung characterizes a gland-associated immune niche. Nat. Genet. 55, 66–77 (2023).
doi: 10.1038/s41588-022-01243-4
Shenoy, A. T. et al. Antigen presentation by lung epithelial cells directs CD4
doi: 10.1038/s41467-021-26045-w
Rudy, G. B. & Lew, A. M. The nonpolymorphic MHC class II isotype, HLA-DQA2, is expressed on the surface of B lymphoblastoid cells. J. Immunol. 158, 2116–2125 (1997).
doi: 10.4049/jimmunol.158.5.2116
Lenormand, C. et al. HLA-DQA2 and HLA-DQB2 genes are specifically expressed in human Langerhans cells and encode a new HLA class II molecule. J. Immunol. 188, 3903–3911 (2012).
doi: 10.4049/jimmunol.1103048
Saichi, M. et al. Single-cell RNA sequencing of blood antigen-presenting cells in severe COVID-19 reveals multi-process defects in antiviral immunity. Nat. Cell Biol. 23, 538–551 (2021).
doi: 10.1038/s41556-021-00681-2
Policard, M., Jain, S., Rego, S. & Dakshanamurthy S. Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism. Virus Res. 301, 198464 (2021).
Kaneko, N. et al. Temporal changes in T cell subsets and expansion of cytotoxic CD4 T cells in the lungs in severe COVID-19. Clin. Immunol. https://doi.org/10.1016/j.clim.2022.108991 (2022).
Meckiff, B. J. et al. Imbalance of regulatory and cytotoxic SARS-CoV-2-reactive CD4 T cells in COVID-19. Cell 183, 1340–1353.e16 (2020).
doi: 10.1016/j.cell.2020.10.001
Wilkinson, T. M. et al. Preexisting influenza-specific CD4
doi: 10.1038/nm.2612
Dan, J. M. et al. A cytokine-independent approach to identify antigen-specific human germinal center T follicular helper cells and rare antigen-specific CD4
doi: 10.4049/jimmunol.1600318
Altman, J. D. et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94–96 (1996).
doi: 10.1126/science.274.5284.94
Wigerblad, G. et al. Single-cell analysis reveals the range of transcriptional states of circulating human neutrophils. J. Immunol. 209, 772–782 (2022).
doi: 10.4049/jimmunol.2200154
Ren, X. et al. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell 184, 1895–1913.e19 (2021).
Liu, C. et al. Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19. Cell 184, 1836–1857.e22 (2021).
COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium. A blood atlas of COVID-19 defines hallmarks of disease severity and specificity. Cell 185, 916–938.e58 (2022).
ISARIC 4C. Coronavirus Clinical Characterisation Consortium. Site set-up https://isaric4c.net/protocols (2020).
Tang, Y. et al. Human nasopharyngeal swab processing for viable single-cell suspension v1. protocols.io https://doi.org/10.17504/protocols.io.bjhkkj4w (2020).
Ziegler, C. G. K. et al. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19. Cell 184, 4713–4733.e22 (2021).
doi: 10.1016/j.cell.2021.07.023
Suo, C. et al. Mapping the developing human immune system across organs. Science 376, eabo0510 (2022).
doi: 10.1126/science.abo0510
Young, M. D. & Behjati, S. SoupX removes ambient RNA contamination from droplet-based single-cell RNA sequencing data. Gigascience 9, giaa151 (2020).
doi: 10.1093/gigascience/giaa151
Heaton, H. et al. Souporcell: robust clustering of single-cell RNA-seq data by genotype without reference genotypes. Nat. Methods 17, 615–620 (2020).
doi: 10.1038/s41592-020-0820-1
Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289–1296 (2019).
doi: 10.1038/s41592-019-0619-0
Traag, V. A., Waltman, L. & van Eck, N. J. From Louvain to Leiden: guaranteeing well-connected communities. Sci. Rep. 9, 5233 (2019).
doi: 10.1038/s41598-019-41695-z
Domínguez Conde, C. et al. Cross-tissue immune cell analysis reveals tissue-specific features in humans. Science 376, eabl5197 (2022).
doi: 10.1126/science.abl5197
Sturm, G. et al. Scirpy: a Scanpy extension for analyzing single-cell T-cell receptor-sequencing data. Bioinformatics 36, 4817–4818 (2020).
doi: 10.1093/bioinformatics/btaa611
Suo, C. et al. Dandelion uses the single-cell adaptive immune receptor repertoire to explore lymphocyte developmental origins. Nat. Biotechnol. 42, 40–51 (2023).
doi: 10.1038/s41587-023-01734-7
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
doi: 10.1186/s13059-014-0550-8
Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).
doi: 10.1186/s13059-017-1382-0
Luecken, M. D. & Theis, F. J. Current best practices in single-cell RNA-seq analysis: a tutorial. Mol. Syst. Biol. 15, e8746 (2019).
doi: 10.15252/msb.20188746
Lopez, R., Regier, J., Cole, M. B., Jordan, M. I. & Yosef, N. Deep generative modeling for single-cell transcriptomics. Nat. Methods https://doi.org/10.1038/s41592-018-0229-2 (2018).
Mayer-Blackwell, K. et al. TCR meta-clonotypes for biomarker discovery with enabled identification of public, HLA-restricted clusters of SARS-CoV-2 TCRs. eLife 10, e68605 (2021).
doi: 10.7554/eLife.68605
Csárdi, G. et al. Igraph. Zenodo https://doi.org/10.5281/ZENODO.3630268 (2023).
Wagih, O. ggseqlogo: a versatile R package for drawing sequence logos. Bioinformatics 33, 3645–3647 (2017).
doi: 10.1093/bioinformatics/btx469
Tareen, A. & Kinney, J. B. Logomaker: beautiful sequence logos in Python. Bioinformatics 36, 2272–2274 (2020).
doi: 10.1093/bioinformatics/btz921
Titsias, M. & Lawrence, N. D. Bayesian Gaussian process latent variable model. Proc. Mach. Learn. Res. 9, 844–851 (2010).
Bingham, E. et al. Pyro: deep universal probabilistic programming. J. Mach. Learn. Res. 20, 1–6 (2019)
Bonilla, E. V., Chai, K. & Williams, C. Multi-task Gaussian process prediction. In Proc. Advances in Neural Information Processing Systems (eds Platt, J. et al.) (Curran Associates, 2007).
Gardner, J. R., Pleiss, G., Weinberger, K. Q., Bindel, D. & Wilson, A. G. GPyTorch: blackbox matrix-matrix gaussian process inference with GPU acceleration. in Advances in Neural Information Processing Systems 31 (eds Samy Bengio, S. et al.) 7587–7597 (NeurIPS, 2018).
Uddin, I. et al. An economical, quantitative, and robust protocol for high-throughput T cell receptor sequencing from tumor or blood. Methods Mol. Biol. https://doi.org/10.1007/978-1-4939-8885-3_2 (2019).
Oakes, T. et al. Quantitative characterization of the T cell receptor repertoire of naïve and memory subsets using an integrated experimental and computational pipeline which is robust, economical, and versatile. Front. Immunol. 8, 1267 (2017).
doi: 10.3389/fimmu.2017.01267
Peacock, T., Heather, J. M., Ronel, T. & Chain, B. Decombinator V4: an improved AIRR compliant-software package for T-cell receptor sequence annotation? Bioinformatics 37, 876–878 (2021).
doi: 10.1093/bioinformatics/btaa758
Mayer, A. & Callan, C. G. Jr Measures of epitope binding degeneracy from T cell receptor repertoires. Proc. Natl Acad. Sci. USA 120, e2213264120 (2023).
doi: 10.1073/pnas.2213264120
Augusto, J. B. et al. Healthcare Workers Bioresource: study outline and baseline characteristics of a prospective healthcare worker cohort to study immune protection and pathogenesis in COVID-19. Wellcome Open Res. 5, 179 (2020).
doi: 10.12688/wellcomeopenres.16051.2
Woodall, M. N. J. et al. Age-specific nasal epithelial responses to SARS-CoV-2 infection. Nat. Microbiol. 9, 1293–1311 (2024).
doi: 10.1038/s41564-024-01658-1
Woodall, M. N. J., Masonou, T., Case, K.-M. & Smith, C. M. Human models for COVID-19 research. J. Physiol. 599, 4255–4267 (2021).
doi: 10.1113/JP281499

Auteurs

Rik G H Lindeboom (RGH)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK. r.lindeboom@nki.nl.
The Netherlands Cancer Institute, Amsterdam, The Netherlands. r.lindeboom@nki.nl.

Kaylee B Worlock (KB)

UCL Respiratory, Division of Medicine, University College London, London, UK.

Lisa M Dratva (LM)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.

Masahiro Yoshida (M)

UCL Respiratory, Division of Medicine, University College London, London, UK.

David Scobie (D)

Research Department of Infection, Division of Infection and Immunity, University College London, London, UK.

Helen R Wagstaffe (HR)

Department of Infectious Disease, Imperial College London, London, UK.

Laura Richardson (L)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Anna Wilbrey-Clark (A)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Josephine L Barnes (JL)

UCL Respiratory, Division of Medicine, University College London, London, UK.

Lorenz Kretschmer (L)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Krzysztof Polanski (K)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Jessica Allen-Hyttinen (J)

UCL Respiratory, Division of Medicine, University College London, London, UK.

Puja Mehta (P)

UCL Respiratory, Division of Medicine, University College London, London, UK.

Dinithi Sumanaweera (D)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Jacqueline M Boccacino (JM)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Waradon Sungnak (W)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
Department of Microbiology, Faculty of Science, and Integrative Computational BioScience Center, Mahidol University, Bangkok, Thailand.

Rasa Elmentaite (R)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
Ensocell Therapeutics, BioData Innovation Centre, Wellcome Genome Campus, Hinxton, UK.

Ni Huang (N)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Lira Mamanova (L)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Rakesh Kapuge (R)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Liam Bolt (L)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Elena Prigmore (E)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Ben Killingley (B)

Department of Infectious Diseases, University College London Hospital, London, UK.

Mariya Kalinova (M)

hVIVO, London, UK.

Maria Mayer (M)

hVIVO, London, UK.

Alison Boyers (A)

hVIVO, London, UK.

Alex Mann (A)

hVIVO, London, UK.

Leo Swadling (L)

Division of Infection and Immunity, Institute of Immunity and Transplantation, University College London, London, UK.

Maximillian N J Woodall (MNJ)

UCL Great Ormond Street Institute of Child Health, London, UK.

Samuel Ellis (S)

UCL Great Ormond Street Institute of Child Health, London, UK.

Claire M Smith (CM)

UCL Great Ormond Street Institute of Child Health, London, UK.

Vitor H Teixeira (VH)

UCL Respiratory, Division of Medicine, University College London, London, UK.

Sam M Janes (SM)

UCL Respiratory, Division of Medicine, University College London, London, UK.

Rachel C Chambers (RC)

UCL Respiratory, Division of Medicine, University College London, London, UK.

Muzlifah Haniffa (M)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Andrew Catchpole (A)

hVIVO, London, UK.

Robert Heyderman (R)

Research Department of Infection, Division of Infection and Immunity, University College London, London, UK.

Mahdad Noursadeghi (M)

Research Department of Infection, Division of Infection and Immunity, University College London, London, UK.

Benny Chain (B)

Research Department of Infection, Division of Infection and Immunity, University College London, London, UK.

Andreas Mayer (A)

Research Department of Infection, Division of Infection and Immunity, University College London, London, UK.

Kerstin B Meyer (KB)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.

Christopher Chiu (C)

Department of Infectious Disease, Imperial College London, London, UK.

Marko Z Nikolić (MZ)

UCL Respiratory, Division of Medicine, University College London, London, UK. m.nikolic@ucl.ac.uk.

Sarah A Teichmann (SA)

Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK. sat1003@cam.ac.uk.
Theory of Condensed Matter, Cavendish Laboratory, Department of Physics, University of Cambridge, Cambridge, UK. sat1003@cam.ac.uk.
Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. sat1003@cam.ac.uk.

Classifications MeSH